Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Kratos Defense & Security Solutions

NVIDIA

The U.S. economy is on a positive trajectory, fueled by robust consumer spending and business investments. With profits rising steadily, there's an encouraging trend of retaining employees, further supporting economic expansion.

The 3 Best Robotics Stocks to Buy in Q2 2024

AbbVie

HCA Healthcare

Eli Lilly

Novo Nordisk

UnitedHealth Group

Vertex Pharmaceuticals

These seven healthcare companies are industry and market leaders. They generally present excellent long-term prospects, too.

Meet The "Magnificent Seven" of Healthcare Stocks

Medtronic

Intuitive Surgical and Medtronic are using AI to improve their medical devices. Both healthcare giants have excellent prospects beyond this promising area.

2 Healthcare Artificial Intelligence (AI) Stocks That Could Be Smart Investment Bets

The robotic-assisted surgery system market could nearly double in size by 2029. Artificial intelligence may improve Intuitive's surgical systems and also boost demand for the business.

Is Intuitive Surgical Stock a Millionaire Maker?

Barron's published an article in February discussing cheap healthcare stocks to buy, noting comments from Janus Henderson Global Life Sciences (MUTF: JAGLX ) co-manager Andy Acker. “At one point in October [2023], we had 232 biotech companies trading below the levels of cash on their balance sheet,” Acker told Barron's.

3 Healthcare Stocks to Buy From 3 of the Best Actively Managed Funds

Intuitive Surgical is now approved to launch its latest surgical robot. The latest da Vinci surgical unit has key features that no competitor has.

1 New Reason to Buy Intuitive Surgical Stock and Hold Forever

Teradyne

Zebra Technologies

Investors looking to invest in the next best industry have probably considered artificial intelligence (AI) or quantum computing. However, these favorite robotics stocks have already transformed various industries, particularly manufacturing and healthcare, by creating new opportunities for automation and efficiency.

Wall Street's Favorite Robotics Stocks? 3 Names That Could Make You Filthy Rich

Intuitive Surgical has made a name for itself with its robotic-assisted surgical systems. Though it faces some near-term headwinds, the company's prospects look exciting.

1 Magnificent Growth Stock to Buy and Hold

Apple

Amazon

Alibaba

Dell Technologies

Alphabet

Microsoft

Oracle

Tesla

Western Digital

The popularity of artificial intelligence (AI) has to do with its application in virtually every sector and industry. Despite being the hottest thing since sliced bread, shares of AI infrastructure titan Nvidia were aggressively sold by three successful billionaire asset managers.

3 Billionaires Are Selling Artificial Intelligence (AI) Stock Nvidia and Buying These 10 AI Stocks Instead

SentinelOne

When seeking out potential investments, focusing on growth stocks can be a lucrative strategy for investors. Innovative companies with solid growth prospects often outperform the market, as represented by the S&P 500 index.

Springtime Profits: 3 Growth Stocks Poised to Bloom in March

iRobot

Symbotic Inc

If you're paying attention, there's a robotics stocks revolution quietly underway. While headlines holler about imminent worker replacement by hordes of AI-enabled robots, the truth is much more optimistic.

Hot Stocks: The 3 Best Opportunities for Investing in Robotics

Intuitive Surgical is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. I saw a 21% increase in sales for their flagship da Vinci procedures robot, which the company expects to continue. Revenue increased 17% to $1.9bn vs 2022 Q4, with a solid and stable gross margin of 66%.

Intuitive Surgical: Great Company, But Looking Overpriced

Canoo

UiPath

Palantir Technologies

Texas Instruments

There are seven stocks making CEOs lose sleep in March this year, reflecting the immense pressures and challenges facing major corporations across various industries. Some companies are reeling from product safety crises that have shaken consumer confidence while exposing them to staggering litigation risks.

7 Stocks That Are Making Other CEOs Lose Sleep at Night

Intuitive Surgical, Inc. (ISRG) da Vinci 5 Conference Call Transcript

Intuitive Surgical (ISRG) announces the FDA clearance for its next-generation robotic system, da Vinci 5, which is likely to improve surgical workflow and save significant time with better care.

Intuitive Surgical's (ISRG) Da Vinci 5 Receives FDA Approval

Intuitive Surgical (NASDAQ: ISRG ) stock is getting a boost on Friday as investors celebrate approval of da Vinci 5 by the Food and Drug Administration (FDA). Da Vinci 5 is the next generation of Intuitive Surgical's multiport robotic system that has been used in more than 7 million procedures.

ISRG Stock Alert: The FDA Is Giving Intuitive Surgical a Big Boost

Intuitive Surgical stock jumped late Thursday after the company won FDA clearance for its next-generation robotic surgery system, da Vinci 5.

Intuitive Surgical Pops After Winning FDA Clearance For Next-Gen Robotic System

Da Vinci 5 builds on decades of Intuitive technology and millions of robotic procedures Da Vinci 5 builds on decades of Intuitive technology and millions of robotic procedures

Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5

Marriott

Netflix

News Corp

Steel Dynamics

Taiwan Semiconductor Manufacturing

AMERCO

If the market's dramatic shifts this year have left you feeling dizzy, you're not alone – but blue-chip stocks might be the anchor you need to regain stability. Amidst the current rally (bubble?

The Blue-Chip Advantage: 7 Stocks for Investors Who Play to Win

Becton, Dickinson and Co.

Globus Medical

Smith & Nephew

Stryker

Zimmer Biomet Hlds

There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain and scarring, quicker recovery times, and improved clinical outcomes.

7 Robotic Surgery Stocks to Buy for the Future of Healthcare

Clearway Energy

Coca-Cola

The US tax refund season brings positive news as the average IRS tax refund, currently at $3,182, reflects a 5.1% increase from last year. Despite a slight dip of 1.7% in the number of tax returns filed the U.S. Internal Revenue Service (IRS) reports a smooth and efficient start to tax filing season.

Refund Riches: 3 Stocks to Buy With Your Tax Windfall

With technology evolving at a break-neck pace, robotics emerges at the forefront of innovation, offering transformative potential across many sectors from manufacturing to healthcare. Hence, for those with a forward-thinking approach, betting on the top robotics stocks to buy presents itself as a lucrative long-term investment realm.

The Top 3 Robotics Stocks to Buy in March 2024

The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $400.59, representing a +0.68% change from its previous close.

Intuitive Surgical, Inc. (ISRG) Advances While Market Declines: Some Information for Investors

DexCom

Intuitive Surgical's opportunities in the robotic-assisted surgery market far outweigh its recent issues. DexCom still has a long way to go to make its devices mainstream among diabetes patients worldwide.

Adding $1,000 to These Top Growth Stocks Would Be a Brilliant Move

The Magnificent Seven are stealing the show this year on the market. They're all technology companies -- but there are opportunities elsewhere, too.

News for Intuitive Surgical Stock (ISRG)